Myriad Genetics (MYGN) CTO Raj Jampa receives 251,889 restricted stock units

Rhea-AI Filing Summary

Jampa Raj reported acquisition or exercise transactions in this Form 4 filing.

MYRIAD GENETICS INC Chief Technology Officer Raj Jampa received an equity grant of 251,889 restricted stock units. The award has no cash purchase price and represents a contingent right to receive an equal number of common shares. According to the terms, the units vest in four equal annual installments beginning on the first anniversary of the grant date, aligning the CTO’s compensation with long-term company performance.

Insights

Equity compensation analyst

Routine CTO RSU grant aligns pay with multi‑year performance.

The filing shows Chief Technology Officer Raj Jampa receiving 251,889 time-based restricted stock units under Myriad Genetics’ 2017 equity incentive plan. There is no purchase price; this is a compensation award rather than an open-market transaction.

The RSUs vest in four equal annual installments starting one year after the grant. This structure encourages the executive to remain with the company and focus on long-term value, but it does not itself indicate any change in the company’s outlook.

Because there are no derivative positions disclosed in this filing and the entire position reflects this grant, the event appears to be a standard refresh or initial equity grant. Its significance for shareholders depends on overall share count and compensation practices, which are not detailed here.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Jampa Raj

Role Chief Technology Officer

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	251,889	$0.00	--

Holdings After Transaction: Common Stock — 251,889 shares (Direct, null)

Footnotes (1)

1. [object Object]

Key Figures

RSUs granted: 251,889 units Purchase price: $0.00 per unit Post-transaction holdings: 251,889 units +1 more

4 metrics

RSUs granted 251,889 units Time-based restricted stock units granted to CTO Raj Jampa

Purchase price $0.00 per unit Grant/award acquisition, compensation not open-market purchase

Post-transaction holdings 251,889 units Total restricted stock units reported following the transaction

Vesting schedule 4 annual installments Vests in four equal annual installments from first grant anniversary

Key Terms

restricted stock units, Equity Incentive Plan, vests in four equal annual installments

3 terms

restricted stock units financial

"Consists of time-based restricted stock units granted pursuant to the Issuer's 2017 Employee, Director and Consultant Equity Incentive Plan."

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

Equity Incentive Plan financial

"granted pursuant to the Issuer's 2017 Employee, Director and Consultant Equity Incentive Plan."

An equity incentive plan is a program that gives employees, executives or directors the right to receive company stock or options to buy stock as part of their pay. Think of it as offering slices of future company profit to motivate people to boost long‑term performance; for investors it matters because it can align employee goals with shareholder value but also increases the number of shares outstanding, which can dilute existing ownership.

vests in four equal annual installments financial

"and vests in four equal annual installments beginning on the first anniversary of the grant date."

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Jampa Raj

(Last) (First) (Middle)

322 NORTH 2200 WEST

(Street)

SALT LAKE CITY UTAH 84116

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
MYRIAD GENETICS INC [ MYGN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Technology Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/01/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/01/2026		A		251,889(1)	A	$0	251,889	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Consists of time-based restricted stock units granted pursuant to the Issuer's 2017 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock and vests in four equal annual installments beginning on the first anniversary of the grant date.

Remarks:

	By: Justin Hunter For: Raj Jampa	06/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What did MYRIAD GENETICS INC (MYGN) disclose about Raj Jampa in this Form 4?

MYRIAD GENETICS INC reported that Chief Technology Officer Raj Jampa received 251,889 restricted stock units as an equity compensation grant. These units are tied to the company’s common stock and will convert into shares as they vest over time.

How many MYGN shares are covered by Raj Jampa’s new restricted stock unit award?

The award covers 251,889 restricted stock units, each representing one potential share of MYRIAD GENETICS INC common stock. All 251,889 units are reported as held following the transaction, reflecting the full size of this grant-based equity position.

Did Raj Jampa buy or sell MYGN stock in the open market?

No open-market buy or sell occurred. The Form 4 shows a grant of 251,889 restricted stock units with a zero dollar price per unit, indicating a compensation award, not a market transaction involving cash paid or received by Raj Jampa.

What are the vesting terms for Raj Jampa’s MYGN restricted stock units?

The restricted stock units vest in four equal annual installments beginning on the first anniversary of the grant date. This means 25% of the 251,889 units vest each year over four years, encouraging multi-year retention and performance alignment.

Under which plan were Raj Jampa’s MYGN restricted stock units granted?

The units were granted under MYRIAD GENETICS INC’s 2017 Employee, Director and Consultant Equity Incentive Plan. This plan authorizes stock-based compensation awards, including restricted stock units that convert into common shares as vesting conditions are satisfied.

How many MYGN shares does Raj Jampa hold after this Form 4 transaction?

Following the grant, Raj Jampa is reported as holding 251,889 shares in the form of restricted stock units. These units represent a contingent right to receive an equal number of common shares as they vest over the four-year schedule.